Aspen Pharmacare Holdings (APN.JO) Aktie Kurs
Aspen Pharmacare Holdings Kurs
De seneste 19 år voksede Aspen Pharmacare Holdingss omsætning med 12,0 % årligt og nåede 34,87 Mrd. ZAR. Indtjening pr. aktie er vokset med 6,1 % om året de seneste 19 år. For Aspen Pharmacare Holdings er nettoavance på 7,6 % ned i forhold til 16,8 % for et par år siden. Ved dagens kurs bliver direkteafkastet cirka 1,28 %. Udlodningsandelen er omkring 28 % af indtjeningen. Udbyttet er vokset med 6,1 % om året de seneste 19 år. Konsensus 12-måneders kursmål for Aspen Pharmacare Holdings er 117,30 ZAR, cirka under kursen med 28,7 %. Af 10 analytikere anbefaler 0 køb — den samlede vurdering er Hold.
Aspen Pharmacare Holdings aktiekurs
Hent disse data via Eulerpool API
100.000 requests/md. gratis · intet kreditkort
Aspen Pharmacare Holdings aktie og aktieanalyse
Hyppigt stillede spørgsmål om Aspen Pharmacare Holdings-aktien
The business model of Aspen Pharmacare Holdings Ltd is focused on the manufacturing and marketing of pharmaceutical and healthcare products. Aspen Pharmacare is a leading global supplier of branded and generic pharmaceuticals, as well as infant nutritionals and consumer healthcare products. With a diverse portfolio of products, the company operates across multiple therapeutic areas including anaesthetics, thrombosis, oncology, and respiratory. Aspen Pharmacare also engages in extensive research and development activities to drive innovation within the pharmaceutical industry. Its commitment to quality and affordability ensures the availability of essential medicines to a wide range of markets worldwide.
Aspen Pharmacare Holdings Ltd is primarily active in the pharmaceutical industry.
The main competitors of Aspen Pharmacare Holdings Ltd in the market are Teva Pharmaceutical Industries Ltd, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
Aspen Pharmacare Holdings Ltd, commonly known as Aspen, is a leading global pharmaceutical company with a rich history and strong background. Founded in 1850 and headquartered in Durban, South Africa, Aspen has grown into a reputable player in the healthcare industry. The company specializes in the manufacturing and distribution of both branded and generic pharmaceutical products across various therapeutic areas. With a diversified portfolio, Aspen operates in more than 150 countries, serving patients and healthcare professionals worldwide. Over the years, Aspen has made strategic acquisitions and formed partnerships to expand its product offerings and global reach. With a commitment to improving patient lives, Aspen continues to drive innovation and deliver quality healthcare solutions globally.
Aspen Pharmacare Holdings Ltd, a leading pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its global presence and diversified its product portfolio. It has successfully acquired and integrated multiple companies, enhancing its market reach and capabilities. Aspen Pharmacare has also developed and launched innovative medicines, contributing to advancements in healthcare. The company has received numerous industry awards and recognition, further highlighting its commitment to excellence. With a strong focus on research and development, Aspen Pharmacare continues to make substantial contributions to the healthcare industry, delivering high-quality solutions to patients worldwide.
Aspen Pharmacare Holdings Ltd is primarily present in various countries and regions worldwide. Some of the key markets where the company operates include South Africa, where it is headquartered, as well as other African countries such as Kenya, Nigeria, and Ethiopia. Additionally, Aspen Pharmacare has a significant presence in Latin American countries including Brazil and Mexico. The company has also expanded its operations into Europe, with a focus on countries like Germany, Spain, Italy, and the United Kingdom. Furthermore, Aspen Pharmacare has a presence in the Asia-Pacific region, including Australia, China, and India.
Aspen Pharmacare Holdings Ltd represents a strong set of values and a clear corporate philosophy. The company aims to provide affordable medicines of high quality to people around the world, thus improving their health and well-being. Aspen Pharmacare values integrity, innovation, and accountability in all aspects of its operations. It focuses on sustainable growth and strategic partnerships to expand its global presence and reach. Aspen Pharmacare is committed to providing access to essential healthcare solutions and ensuring patient safety. With its dedicated workforce and commitment to excellence, Aspen Pharmacare continues to make a positive impact in the pharmaceutical industry.
Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 120,02 ZAR for Aspen Pharmacare Holdings-aktien (median: 117,30 ZAR), svarende til -27,0 % i forhold til seneste kurs. Konsensus bygger på 10 analytikervurderinger.
10 analytikere vurderer i øjeblikket Aspen Pharmacare Holdings-aktien: 0 anbefaler køb, 6 hold og 4 salg.
Omregnet til den aktuelle valutakurs handles Aspen Pharmacare Holdings-aktien til 8,84 EUR (164,45 ZAR).
Aspen Pharmacare Holdings-aktien (APN.JO) er noteret på 5 børser, herunder: JSE (Johannesburg) (APN.JO), Frankfurt (LDZA.F), München (LDZA.MU), Düsseldorf (LDZA.DU).
Aspen Pharmacare Holdings Ltd is an international pharmaceutical company based in South Africa. The company specializes in the production and distribution of pharmaceuticals, biopharmaceuticals, and active ingredients. It is one of the largest manufacturers of generics in Africa. The company's business model is characterized by intensive R&D work and a strong presence in Africa. It produces a wide range of pharmaceutical products for various fields such as psychiatry, oncology, gastroenterology, and pain therapy. Aspen is also a significant provider of veterinary medicines. One of the key aspects of its business model is the production of generics, offering cost-effective alternatives to branded products. This allows Aspen to establish a strong presence and achieve high market penetration in markets with limited investment requirements. The company has expanded its business in Europe and Asia, in addition to its strong presence in Africa. This geographical diversification allows Aspen to reach a broad customer base and minimize risks. Besides its products, Aspen also offers tailored services such as shipping, storage, and logistics management to ensure fast and efficient delivery to customers. The company has also expanded its presence in biopharmaceuticals through the acquisition of ThromboGenics in 2013, making it a leading provider of platelet activating factors. Aspen is committed to social responsibility and has initiated various initiatives to improve access to affordable medical products in Africa. Overall, Aspen Pharmacare Holdings Ltd's business model is based on its wide range of products and services, strategic focus on the African market, and effective implementation of its strategy, which has made it one of the largest and fastest-growing pharmaceutical companies in Africa.
-omsætningen for Aspen Pharmacare Holdings er 34,87 Mrd. ZAR. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.
-overskuddet for Aspen Pharmacare Holdings er 2,65 Mrd. ZAR. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for Aspen Pharmacare Holdings er i øjeblikket 27,55. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Aspen Pharmacare Holdings-aktien.
Pris-til-salgs-forholdet (P/S) for Aspen Pharmacare Holdings er i øjeblikket 2,09. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Aspen Pharmacare Holdings-aktien.
AlleAktien-kvalitetsscore for Aspen Pharmacare Holdings er 1/10.
ISIN for Aspen Pharmacare Holdings er ZAE000066692. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Aspen Pharmacare Holdings er A0ET80. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Aspen Pharmacare Holdings er APN.JO. Tickersymbolet bruges til at handle Aspen Pharmacare Holdings-aktier på børsen.
Aspen Pharmacare Holdings aktie
Aspen Pharmacare Holdings Peer Group
Aspen Pharmacare Holdings Ticker
Aspen Pharmacare Holdings FIGI
Alle fundamentale data om Aspen Pharmacare Holdings i deep dive
Vores aktieanalyse af Aspen Pharmacare Holdings-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Aspen Pharmacare Holdings. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: